19150, Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19150, Philadelphia, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.

An estimate of 92.20 percent of the residents in 19150 has some form of health insurance. 45.45 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 63.21 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19150 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 4,157 residents under the age of 18, there is an estimate of 512 pediatricians in a 20-mile radius of 19150. An estimate of 86 geriatricians or physicians who focus on the elderly who can serve the 5,430 residents over the age of 65 years.

In a 20-mile radius, there are 92,626 health care providers accessible to residents in 19150, Philadelphia, Pennsylvania.

**Prostate Cancer Score Analysis: Philadelphia, ZIP Code 19150 & Primary Care**

This analysis assesses the landscape of prostate cancer care within Philadelphia, specifically focusing on the 19150 ZIP code and the broader context of primary care availability. The aim is to evaluate the quality, accessibility, and resources available to patients, culminating in a "Prostate Cancer Score" that reflects the overall health of the system. This score considers various factors, including physician availability, specialized care access, technological integration, and support services.

The cornerstone of effective prostate cancer care is the availability of skilled physicians. In 19150, a comprehensive analysis requires examining the physician-to-patient ratio, specifically for primary care physicians (PCPs) and urologists. A low ratio, indicating fewer doctors per patient, can lead to delayed diagnoses, longer wait times for appointments, and reduced opportunities for preventative care. The analysis would need to compare this ratio to both the Philadelphia average and national benchmarks to gauge the relative accessibility of care within the ZIP code.

Primary care plays a critical role in early detection and management. PCPs are often the first point of contact, responsible for screening, risk assessment, and referrals to specialists. The availability of primary care, therefore, directly impacts the timeliness of prostate cancer diagnosis and treatment. Philadelphia, as a major metropolitan area, presents a diverse landscape of primary care practices. Evaluating these practices involves assessing their capacity to handle a high volume of patients, their commitment to preventative care, and their ability to coordinate care with urologists and other specialists.

Beyond raw numbers, the quality of care is paramount. The analysis would investigate the existence of standout practices within 19150 and the broader Philadelphia area. This includes identifying practices known for their expertise in prostate cancer screening, diagnosis, and treatment. Factors considered include the use of advanced diagnostic tools (e.g., MRI fusion biopsy), the adoption of minimally invasive surgical techniques, and the availability of comprehensive treatment options, such as radiation therapy and hormone therapy. Reputation, patient reviews, and physician qualifications are all essential data points.

Telemedicine has revolutionized healthcare delivery, particularly in increasing access to specialists and follow-up care. The extent of telemedicine adoption among physicians in 19150 and Philadelphia is a crucial aspect of the Prostate Cancer Score. Practices that embrace telemedicine, offering virtual consultations, remote monitoring, and online patient portals, are better positioned to serve patients, especially those with mobility limitations or those living in underserved areas. The analysis would assess the types of telemedicine services offered, the ease of access, and the integration of these services into the overall care plan.

Prostate cancer, and cancer in general, can significantly impact a patient's mental and emotional well-being. The availability of mental-health resources is, therefore, an integral component of comprehensive care. The analysis will examine the presence of on-site or readily accessible mental health professionals, support groups, and counseling services within the practices and healthcare networks serving 19150. This includes assessing the integration of mental health services into the treatment plan, the availability of resources for both patients and their families, and the overall awareness of the importance of mental health in cancer care.

The Prostate Cancer Score will be derived from a weighted aggregation of the factors discussed above. The weighting will reflect the relative importance of each factor in determining the quality and accessibility of care. For example, physician-to-patient ratios and the availability of primary care will be given significant weight, as they directly impact the ability of patients to access care. The adoption of telemedicine and the availability of mental health resources will also be given considerable weight, as they enhance the overall patient experience and support comprehensive care. The final score will provide a snapshot of the prostate cancer care landscape in 19150 and Philadelphia.

The analysis would also consider the presence of community outreach programs and educational initiatives. These programs can play a vital role in raising awareness about prostate cancer, promoting early detection, and providing support to patients and their families. The analysis will assess the extent to which physicians and healthcare organizations participate in these programs, and the impact they have on the community.

Moreover, the analysis will evaluate the cost of care. This includes examining the cost of screenings, diagnostic tests, treatment options, and follow-up care. The analysis will also assess the availability of financial assistance programs and the affordability of care for patients in 19150 and Philadelphia.

In conclusion, the Prostate Cancer Score for 19150 and the broader Philadelphia area is a dynamic measure that reflects the quality, accessibility, and resources available to patients. By considering physician availability, specialized care access, technological integration, mental health support, and community outreach, the score provides a comprehensive assessment of the prostate cancer care landscape. This assessment is crucial for identifying areas of strength and weakness and for guiding efforts to improve the overall health of the system.

To further explore the spatial distribution of these factors and visualize the data, consider utilizing the power of geospatial analysis. CartoChrome maps can provide a visual representation of physician density, access to specialized care, and the location of support services within Philadelphia. This can help identify areas with limited access to care and inform targeted interventions.

**Call to Action:** Explore the power of geospatial analysis and visualize the prostate cancer care landscape with CartoChrome maps. Gain a deeper understanding of the healthcare environment in Philadelphia and identify opportunities for improvement.